Shwen Gwee
AI & Digital Innovation Leader
Shwen Gweesecurehost2025-10-02T17:19:25+00:00
October 2025
In this DHCG Disruptive Dose episode, Mark Barr of The DHC Group and Shwen Gwee explore AI’s transformative impact on pharmaceutical sales and marketing. Gwee identifies key applications including back-office automation, patient support programs connecting physicians, pharmacies, and payers, and ambient listening tools that reduce administrative burden—achieving adoption rates far faster than EMRs. He emphasizes treating AI initiatives like clinical trials, moving from pilot to scale through phased testing while maintaining human oversight to address bias and hallucinations. The conversation highlights a “real inflection point” as AI-powered answer engines like Google’s Gemini, Open Evidence, and Doximity’s tools become the “true front door” to medical information, finally giving physicians one place to find everything. However, this shift threatens brand websites and publishers with declining traffic as these platforms deliver answers without requiring click-throughs. Gwee concludes that pharma must reimagine content strategy to surface effectively in these new engines and reach physicians at the point of decision.